Interestingly, absence of CD11c+CD40+ cells did reduce hepatic inflammation during NASH, indicating that CD11c+CD40+ cells have a strong (lipid driven) immune-modulatory function. The gene discussed is CD40; the disease is metabolic dysfunction-associated steatohepatitis.